Revolution Medicines shares drop after Merck buyout talks collapse over price. Deal was valued at $28-32B before negotiations ...

The latest update to the Merck stock story centers on a revised price target, reflecting how analysts are reassessing the ...

Merck & Co., Inc. (NYSE:MRK) is included among the 15 Best S&P 500 Dividend Stocks to Buy in 2026. On January 20, TD Cowen ...

The collapse of the talks sent Revolution Medicines’ shares tumbling 20.9% in premarket trading on Monday. This retreat ...

It doesn't look like the company will end up in the arms of an acquirer soon, after all.

Moderna shares are down on Monday, pulling back following a recent report highlighting its latest cancer trial results.

Wall Street expects a year-over-year increase in earnings on higher revenues when Merck (MRK) reports results for the quarter ...

Merck & Co., Inc. (NYSE:MRK) is included among Dividend Contenders List: Top 20 Stocks. Reuters reported that Merck & Co., ...

Erasca stock fell Monday despite no company news, after reports said Merck ended acquisition talks with cancer drugmaker ...

If promising results on a skin cancer vaccine from Moderna and Merck lead to a new launch, the Covid-19 era darling's stock could revive after a 91% fall from its peak.

A Wall Street Journal report said there was a possibility of talks restarting between Merck and Revolution Medicines, or that ...

Markets are treading carefully ahead of a Fed rate decision and a big week of earnings from the likes of Apple and Meta.